Whilst the molecular trigger of the stage 1 transition remains unknown, the understanding ascertained could imply that appearance of DAM occurs too late or in insufficient numbers to combat AD when particular genetic backgrounds are present (e.g. rare variants of TREM2) or during normal ageing. Here, TREM2 is linked to Alzheimer disease.